The Veesler Lab Profile picture
May 10 24 tweets 14 min read
We analyzed human plasma, mucosal and memory antibody responses against #SARSCoV2 and found a pan-variant neutralizing antibody!

Led by @YoungjunPark11 Dora Pinto @coronalexington @JZhuoming

Collab. with @DavideCorti6

@HHMINEWS
@Vir_Biotech

1/24

biorxiv.org/content/10.110…
We assessed plasma neutralizing activity from humans previously infected in 2020 (WA-1-like) and then vaxed 2x or 3x, or vaxed before Delta or #Omicron BA.1 breakthrough infection or vaxed-'only' 3x

2/24
#Omicron breakthrough cases had highest neutralizing activity against #SARSCoV2 variants, possibly due to exposure to BA.1 spike whereas neutralization of SARS-CoV-1 was low for all cohorts, due to genetic and antigenic divergence of the latter spike

3/24
We found that ≥80% of IgGs secreted by memory B cells (Bmem) from #Omicron breakthrough cases bound the Wuhan-Hu-1, BA.1, BA.2 and Delta RDBs & ≥90% of them blocked binding to ACE2 (a correlate of neutralization). No BA.1- or BA.2 RBD-specific antibodies were found!

4/24
This illustrates how immunological imprinting from prior exposure can strongly affect responses to antigenically novel antigens: #Omicron infection preferentially expanded existing B cell pools primed by vaccination and elicited cross-reactive plasma cells and antibodies

5/24
Conversely, Bmem-derived RBD-specific secreted IgGs obtained from Omicron primary infections were present at low frequency and were mostly specific for BA.1 and BA.2!

6/24
We found a lower frequency of Bmem secreting IgGs recognizing antigenic site Ia/Ib (ACE2-binding site) and II for #Omicron breakthrough vs infected-vaxed cases, consistent with the presence of several immune escape mutations in the Omicron RBD.

7/24
For a definition of #SARSCoV2 RBD antigenic sites, please see

sciencedirect.com/science/articl…

8/24
We detected mucosal neutralizing activity against Wuhan-Hu-1/G614 and BA.1 in nasal swabs (ie the site of viral entry) for #Omicron breakthrough samples up to a month post symptom onset but not in vaccinated-only individuals

9/24
These findings motivate the development and evaluation of a next generation of vaccines administered intranasally, an idea shared by @VirusesImmunity and others

washingtonpost.com/health/2022/04…

10/24
Evaluation of the monoclonal antibodies (mAbs) currently used in the clinic revealed that they all experience reductions of neutralizing activity (to various extent) against BA.1, BA.2, BA.2.12.1, BA.3, BA.4 and BA.5.

11/24
The S2X324 mAb stood out as it neutralized all SARS-CoV-2 variants tested ultrapotently, including BA.1, BA.2.12.1, BA.2, BA.3, BA.4 and BA.5 and cross-reacted with the sarbecovirus clade 1b Pangolin-GD RBD, but did not recognize more divergent sarbecovirus RBDs

12/24
To understand the pan-variant S2X324 inhibitory activity, we determined a #cryoEM structure of the Omicron BA.1 spike trimer bound to the S2X324 Fab which binds to an RBD epitope partially overlapping with antigenic sites Ia/Ib and IV and accommodates #Omicron mutations

13/24
S2X324 overlaps partially with the ACE2-binding site on the RBD and hinders receptor engagement sterically, thereby inhibiting viral attachment to the host surface

14/24
Prophylactic (pre-exposure) or therapeutic (post-exposure) administration of S2X324 protects hamsters challenged with the SARS-CoV-2 Delta and BA.2 variants, making it an ideal candidate for clinical development

15/24
Although S2X324 was isolated before the emergence of #Omicron, it illustrates the type of antibodies that can be recalled upon #Omicron breakthrough infection of convalescent or vaxed individuals

16/24
In summary, exposure to #Omicron primarily leads to a recall of existing Bmem specific for epitopes shared by multiple SARS-CoV-2 variants rather than by priming naïve B cells recognizing Omicron-specific epitopes (at least up to 100 days post breakthrough infection)

17/24
Although immune imprinting may be beneficial in stimulating responses to cross-reactive SARS-CoV-2 epitopes, antibody responses to some #Omicron-specific epitopes were markedly diminished by prior antigenic exposure

18/24
Our data concur with boosting pre-immune macaques with Beta or #Omicron mRNA spike or Beta RBD nanoparticle eliciting ≈high titers of antibodies broadly neutralizing variants relative to Wuhan-Hu-1-based vaccines

19/24

sciencedirect.com/science/articl…

biorxiv.org/content/10.110…
The limited cross-variant neutralization elicited by #Omicron primary infection in humans along with our data on the specificity of Bmem indicate that an #Omicron vaccine might elicit narrow(er) antibody responses

20/24

researchsquare.com/article/rs-153…
This suggests that a heterologous prime-boost or a multivalent approach might be be suited.

21/24
Our data show that Omicron breakthrough infections did not elicit high titers of pan-sarbecovirus neutralizing antibodies (e.g., directed against SARS-CoV-1), as opposed to SARS survivors who received #SARSCoV2 vaccines

nejm.org/doi/full/10.10…

22/24
These data underscore the need to develop vaccines eliciting broad sarbecovirus immunity

23/24

sciencedirect.com/science/articl…
Thank you so much @sprouse_kaitlin @AminAddetia @johnbowenbio Cameron Stewart & our wonderful collaborators including @HelenChuMD @LanzavecchiaB @vsv512 @DrLisaPurcell @neyts_johan @AnnaDeMarco83 @FLempp @HaVanDang2712 @SkiClimbSciNick & many others

24/24

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with The Veesler Lab

The Veesler Lab Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @veeslerlab

Mar 17
Excited to share our latest serological data evaluating plasma neutralizing antibody responses and immune evasion associated with the constellation of spike mutations present in the #Omicron BA.1 and BA.2 variants.

Led by @johnbowenbio

1/13

biorxiv.org/content/10.110…
We compared side-by-side the plasma neutralizing activity elicited in humans by seven #COVID19 vaccines (Moderna, Pfizer, Novavax, Janssen, AstraZeneca, Sputnik V and Sinopharm) or SARS-CoV-2 Washington-1 infection. We cover mRNA, Ad-vectored and protein subunit vaccines!

2/13
We found that the large number of BA.1 and BA.2 spike mutations severely dampen plasma neutralizing activity elicited by infection or primary vaccine series, with a more marked effect for BA.1 compared to BA.2 across all groups.

3/13
Read 13 tweets
Feb 9
Throughout the pandemic, we have been puzzled with inconsistencies in the observed breadth of polyclonal serum neutralizing antibodies against #SARSCoV2 variants in mice vs humans or non-human primates.

Led by @coronalexington

@HHMINEWS

1/6

biorxiv.org/content/10.110…
Serum neutralizing antibodies titers represent the current best correlate of protection against #SARSCoV2 used to evaluate and compare vaccine-elicited immunity in animal models and humans.

For an example see this paper.

2/6

nature.com/articles/s4158…
Vaccine-elicited serum neutralizing activity was less sensitive to #SARSCoV2 variants (less affected) in mice than in non-human primates or humans, regardless of overall titer, vaccine platform (protein subunit vs mRNA), mouse strain, cell type, or antigen (RBD vs spike)...

3/6
Read 6 tweets
Jan 26
Delighted to share our study of the #SARSCoV2 E406W spike mutant describing how a single amino acid mutation mediates escape from the REGN10987/REGN10933 antibody cocktail despite residing outside their epitopes

Led by @AminAddetia

1/8

biorxiv.org/content/10.110…
The E406W mutation was previously described by @tylernstarr @AllieGreaney (along with @AminAddetia during his rotation in) @jbloom_lab using deep-mutational scanning and neutralization assays.

2/8

science.org/doi/10.1126/sc…
We determined a #CryoEM structure of the E406W spike trimer and observed a remodeling of the receptor-binding domain (RBD), hindering binding of clinical antibodies such as the REGN10987/REGN10933 cocktail or COV2-2130

3/8
Read 8 tweets
Jan 25
The peer-reviewed version of our manuscript describing the structures of the #SARS_CoV_2 #OmicronVariant spike bound to the clinical S309 antibody (sotrovimab parent) and receptor-binding domain bound to ACE2 (and S309/S304) is now available here.

science.org/doi/10.1126/sc…

1/7
Here is the original thread describing this study



2/7
During the reviewing process, we added binding data to show that most clinical antibodies have reduced or abrogated binding to the #OmicronVariant spike trimer relative to Wuhan-Hu-1 spike

3/7
Read 7 tweets
Jan 6
The peer-reviewed version of our manuscript describing the broadly neutralizing sarbecovirus antibody S2K146 can be found here

science.org/doi/10.1126/sc…

1/5
Here is the original thread describing these results.



2/5
Compared to our original @biorxivpreprint submission, we added data showing that S2K146 binds the reconstructed RBD ancestor of all sarbecoviruses (AncAsia)

3/5 Image
Read 6 tweets
Dec 31, 2021
We characterized the structural basis of #SARSCoV2 #OmicronVariant binding to the host ACE2 receptor and neutralization by the S309/sotrovimab clinical antibody therapeutic!

Led by @Dr_MattMcCallum & Nadine Czudnochowski Collab w Gyorgy Snell

1/8

biorxiv.org/content/10.110…
We show that the #OmicronVariant spike NTD antigenic supersite is structurally rearranged, relative to the Wuhan-Hu-1 NTD, explaining the loss of binding and neutralization by a panel of NTD-targeted monoclonal antibodies we recently evaluated (nature.com/articles/d4158…).

2/8
The #OmicronVariant spike S2 subunit (fusion machinery) harbors mutations introducing additional electrostatic contacts with the S1 subunit, which might explain the reduced S1 shedding described in this preprint (biorxiv.org/content/10.110…)

3/8
Read 8 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(